ARQT Market Cap & Key Metrics
Arcutis Biotherapeutics, Inc.
$27.39
+$1.19(+4.52%)
40
Overall
20
Value
41
Tech
60
Quality
Market Cap
$3.46B
Volume
2.21M
52W Range
$19.30 - $34.80
Target Price
$40.50
ARQT market cap is $3.46B. This page lists Arcutis Biotherapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
ARQT Key Metrics
- Market cap
- $3.46B
- P/E ratio (current-year EPS estimate)
- 82.98
- EPS estimate, current year
- $0.33
- EPS growth, 3-year
- +71.57%
- Value score
- 20
- Quality score
- 60
- Technical score
- 41
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $372.07M | $166.54M | $29.19M | $3.69M | - |
| EBITDA | $1.78M | -$110.27M | -$227.41M | -$306.83M | -$218.94M |
| EPS | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ARQT | $27.39 | +4.5% | 2.21M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Arcutis Biotherapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW